Evidence map›Paper›PMID 7513049›Full record

ArticleMolecular and cellular biology1994

Activation of the glycoprotein hormone alpha-subunit promoter by a LIM-homeodomain transcription factor.

M S Roberson, W E Schoderbek, G Tremml, R A Maurer

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 155 citations in OpenAlex.

  1. Review
  2. Review
  3. Evidence for Fgf and Wnt regulation ofFrontiers in cell and developmental biology · 2025
    Article
  4. Modification of Lhx2 activity forFrontiers in cell and developmental biology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Impaired FSHbeta expression in the pituitaries of Foxl2 mutant animals.Molecular endocrinology (Baltimore, Md.) · 2011
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M S RobersonDepartment of Cell Biology and Anatomy, Oregon Health Sciences University, Portland 97201.
W E Schoderbek
G Tremml
R A Maurer
Oregon Health & Science University · US

Funding

REGULATION OF LUTEINIZING HORMONE B GENE EXPRESSIONF32HD007555 · NICHD · UNIVERSITY OF IOWA · PI ROBERSON, MARK S · 1992 to 1994
–
PITUITARY GLYCOPROTEIN HORMONE GENE EXPRESSIONR01DK036407 · NIDDK · UNIVERSITY OF IOWA · PI MAURER, RICHARD A · 1986 to 1998
–
NICHD NIH HHS HD07555NIDDK NIH HHS DK36407
6 · The paper itself

Abstract

Recently, a pituitary-specific enhancer was identified within the 5' flanking region of the mouse glycoprotein hormone alpha-subunit gene. This enhancer is active in pituitary cells of the gonadotrope and thyrotrope lineages and has been designated the pituitary glycoprotein hormone basal element (PGBE). In the present studies, we sought to isolate and characterize proteins which interact with the PGBE. Mutagenesis experiments identified a 14-bp imperfect palindrome that is required for binding of a factor which is present in cells of gonadotrope and thyrotrope lineages but not in other cells. Screening of a mouse cDNA library with a DNA probe containing the imperfect palindrome resulted in the isolation of a LIM-homeodomain transcription factor. The cDNA predicts a mouse protein which is 94% identical to the recently described rat LIM-homeodomain protein LH-2. LH-2 contains two zinc fingers (LIM domain) and a consensus homeodomain. Hybridization analysis revealed relatively high expression of LH-2 mRNA in the central nervous system and in pituitary cells of the gonadotrope and thyrotrope lineages. Lower or nondetectable levels of LH-2 mRNA were found in other pituitary cells and tissues, including placental cells. Recombinant LH-2 homeodomain was found to selectively bind to the previously identified imperfect palindrome in the PGBE. Point mutations in the PGBE resulted in parallel losses in the binding of a nuclear factor from a cell line of the gonadotrope lineage and recombinant LH-2-binding activity. Use of an antibody to LH-2 provided evidence that endogenous PGBE-binding activity from cells of the gonadotrope lineage involves a protein which is immunologically related to LH-2. Expression of LH-2 in two heterologous cell types resulted in activation of a reporter gene containing the mouse alpha promoter. These data suggest that the LIM-homeodomain factor LH-2 plays a role in stimulating tissue-specific expression of the mouse glycoprotein hormone alpha subunit. The finding that a LIM-homeodomain protein can stimulate expression of one of the earliest markers of pituitary differentiation raises the possibility that this factor plays a role in cell lineage determination in the pituitary.

Indexed as

Gene Expression RegulationHomeodomain ProteinsPromoter Regions, GeneticAnimalsBase SequenceBinding SitesCell LineCell NucleusChromatography, AffinityDNA-Binding ProteinsEnhancer Elements, GeneticGene LibraryGlycoprotein Hormones, alpha SubunitHumansLIM-Homeodomain ProteinsMiceDNA-Binding ProteinsGlycoprotein Hormones, alpha SubunitHomeodomain ProteinsLHX2 protein, humanLhx2 protein, mouseLhx2 protein, ratLIM-homeodomain protein LH-2LIM-Homeodomain ProteinsOligonucleotide ProbesThyrotropinTranscription Factors

Identifiers

PMID7513049
PMCPMC358666
OpenAlexW2107161940

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.